We organize cannabis research to demonstrate medical benefits of specific cannabis products for diseases and conditions.
CannaTrials provides cannabis research and education services to:
Tuesday, January 30, 2019
CannaTrials announces The PROMMISE Study, a nationwide survey of how patients use medical marijuana to address symptoms of health conditions.
All US residents are invited to participate in this Study, which will be used to educate healthcare professionals, the public, government, and producers on how individuals are using cannabis in various forms to medicate. It’s time we had science behind the claims.
Please join us TODAY. Results will be published before July 1.
Medical Cannabis is:
- Evaluated fairly by medical science and government for its benefits and risks for public consumption.
- Tested via clinical trials through local partnerships of consumers, physicians, processors, growers, and dispensaries.
- Manufactured and labeled accurately with content information and proven health benefits.
- Regulated at the State level to reflect State values and achieve mutual benefits for all parties.
Raphael Mechoulam, the discoverer of the bodily endocannabinoid receptor system, and possibly cannabis’ greatest researcher, considers cannabis a “medicinal treasure trove waiting to be discovered.”
How can we help you?
Who we are
Our goal at CannaTrials is to initiate and support cannabis-based research. We can help you design, implement, manage and close-out your study. We have decades of experience and thousands of trials under our belt.
We bring together patients, investigators and study sponsors to help assure rapid, accurate, and ethical recruitment, retention, and compliance of cannabis studies. Our predictive modeling helps assure success.